# Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparative-effectiveness-of-glp-1-receptor-agonists-on-glycaemic-control-body/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Haiqiang Yao,Anqi Zhang,Delong Li,Yuqi Wu,Chong‐Zhi Wang,Jin‐Yi Wan,Chun‐Su Yuan |
| Citations | 507 |
| DOI | 10.1136/bmj-2023-076410 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.bmj.com/content/bmj/384/bmj-2023-076410.full.pdf |
| OpenAlex ID | https://openalex.org/W4391309422 |
| PMID | 38286487 |
| Type | review |
| Year | 2024 |

## Paper authors

- [Anqi Zhang](https://scholariq.org/researchers/anqi-zhang/)

## Paper journal

- [BMJ](https://scholariq.org/journals/bmj-2/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.